[Summary] 纳米抗体新药研发商
上海洛启生物医药技术有限公司专业致力于创新生物药成果产业化和靶向免疫抗癌药物的研发。拥有超过1000余平方米的研发生产基地,建立了完善的纳米抗体新药研发体系,将纳米抗体早期筛选研发和候选药物的后期工艺开发有效结合,形成系统完整的研发体系,在国内甚至在国际上均处于领先水平。目前公司已建立起一条包括多个纳米抗体新药品种的产品链,覆盖肿瘤、眼底病、自身免疫疾病、心血管病等疾病领域。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows